We are live on
!
Find out more
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
40 hedge funds and large institutions have $366M invested in Evelo Biosciences, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
250% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 6
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
11% more capital invested
Capital invested by funds: $329M → $366M (+$37.1M)
8% more funds holding
Funds holding: 37 → 40 (+3)
Holders
40
Holders Change
+3
Holders Change %
+8.11%
% of All Funds
0.89%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
6
Increased
21
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$4.13M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$2.16M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$745K |
| 4 |
State Street
Boston,
Massachusetts
|
+$714K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$703K |
